Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Penson

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
BMC Geriatrics|January 16, 2024
Pharmacist-led intervention for older people with atrial fibrillation in long-term care (PIVOTALL study): a randomised pilot and feasibility studyLeona A Ritchie, Peter E Penson, Asangaedem Akpan, et al.
The American Journal of Medicine|August 24, 2022
Integrated Care for Atrial Fibrillation Management: The Role of the PharmacistLeona A Ritchie, Peter E Penson, Asangaedem Akpan, et al.
Journal of Clinical Medicine|November 27, 2019
Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic ImplicationsArmita Mahdavi Gorabi, Nasim Kiaie, Saeideh Hajighasemi, et al.
Metabolism: Clinical and Experimental|September 25, 2020
Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stoneShiva Ganjali, Vanessa Bianconi, Peter E Penson, et al.
Foods (Basel, Switzerland)|April 16, 2020
Intake of Caffeine and Its Association with Physical and Mental Health Status among University Students in BahrainHaitham Jahrami, Mana Al-Mutarid, Peter E Penson, et al.
Progress in Cardiovascular Diseases|December 31, 2020
How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitorsBarbara Cybulska, Longina Kłosiewicz-Latoszek, Peter E Penson, et al.
Drug Discovery Today|September 17, 2019
A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposomeNasim Kiaie, Armita Mahdavi Gorabi, Peter E Penson, et al.
Journal of Drug Targeting|August 6, 2024
Advancements in curcumin-loaded PLGA nanoparticle delivery systems: progressive strategies in cancer therapySanaz Keshavarz Shahbaz, Khadijeh Koushki, Omid Izadi, et al.
Atherosclerosis|August 21, 2021
Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registryKrzysztof Dyrbuś, Mariusz Gąsior, Piotr Desperak, et al.
British Journal of Clinical Pharmacology|July 18, 2022
Identifying and addressing pill aversion in adults without physiological-related dysphagia: A narrative reviewAlice P McCloskey, Peter E Penson, Yincent Tse, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
BMC Geriatrics|January 16, 2024
Pharmacist-led intervention for older people with atrial fibrillation in long-term care (PIVOTALL study): a randomised pilot and feasibility studyLeona A Ritchie, Peter E Penson, Asangaedem Akpan, et al.
The American Journal of Medicine|August 24, 2022
Integrated Care for Atrial Fibrillation Management: The Role of the PharmacistLeona A Ritchie, Peter E Penson, Asangaedem Akpan, et al.
Journal of Clinical Medicine|November 27, 2019
Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic ImplicationsArmita Mahdavi Gorabi, Nasim Kiaie, Saeideh Hajighasemi, et al.
Metabolism: Clinical and Experimental|September 25, 2020
Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stoneShiva Ganjali, Vanessa Bianconi, Peter E Penson, et al.
Foods (Basel, Switzerland)|April 16, 2020
Intake of Caffeine and Its Association with Physical and Mental Health Status among University Students in BahrainHaitham Jahrami, Mana Al-Mutarid, Peter E Penson, et al.
Progress in Cardiovascular Diseases|December 31, 2020
How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitorsBarbara Cybulska, Longina Kłosiewicz-Latoszek, Peter E Penson, et al.
Drug Discovery Today|September 17, 2019
A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposomeNasim Kiaie, Armita Mahdavi Gorabi, Peter E Penson, et al.
Journal of Drug Targeting|August 6, 2024
Advancements in curcumin-loaded PLGA nanoparticle delivery systems: progressive strategies in cancer therapySanaz Keshavarz Shahbaz, Khadijeh Koushki, Omid Izadi, et al.
Atherosclerosis|August 21, 2021
Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registryKrzysztof Dyrbuś, Mariusz Gąsior, Piotr Desperak, et al.
British Journal of Clinical Pharmacology|July 18, 2022
Identifying and addressing pill aversion in adults without physiological-related dysphagia: A narrative reviewAlice P McCloskey, Peter E Penson, Yincent Tse, et al.
Pageof 10